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Extracellular vesicles (EVs), including the nano-sized exosomes, have the capacity to transfer multiple
functional molecules between cells. In cell culture experiments, fetal bovine serum (FBS) is often used to
supplement cell culture medium as a nutrient, but it is important to know that the FBS also contain significant
quantities of EVs. The aim of the current study was to determine whether the FBS EVs can influence cultured
cellphenotype,andsecondlytodeterminetheefficiencyofFBS-EVeliminationprotocols.Firstly,FBSthathad
not been depleted of EVs induced a migratory phenotype in a lung cancer epithelial cell line (A549 cells), an
effect that could be mimicked by isolated FBS EVs alone. FBS-derived EVs also contained RNA, which was
protected from consecutive proteinase K and RNase A treatment. Comparison of common isolation protocols
suggested that an 18-hour centrifugation period eliminates approximately 95% of RNA-containing FBS EVs,
whereasa1.5-hourprotocolisinsufficient.Inconclusion,thisstudyshowsthatFBSEVssubstantiallyinfluence
cultured cell behaviour, but also that they can be virtually removed byan 18-hour ultracentrifugation protocol.
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E
xosomes are small extracellular vesicles (EVs)
that are 40100 nm in size, and are considered
to be released by most cells via an intracellular
origin involving multivesicular bodies (1,2). However,
several other subgroups of EVs also exist, including
larger microvesicles thought to be released directly from
the cell surface (3). EVs are thought to take part in
cell-to-cell communication, as they can shuttle proteins,
lipids, and RNA between cells (46), and the status of
the producing cells determines the signal conveyed (6,7).
EVs are also found in all body fluids, such as serum,
saliva, breast milk, and urine (8,9). As cell culture
experiments often involve the presence of fetal bovine
serum (FBS), it is possible that vesicles present in the FBS
can influence experimental results. Indeed, it has been
suggested that FBS-derived EVs may influence results in
cell biology, such as growth of breast cancer cell lines
(10). Also FBS-derived EVs are a major cause of concern
as these vesicles could contaminate EVs derived from
cell cultures (11,12). Therefore, EVs are often removed
from the FBS prior to use in cell culture experiments,
by the use of different depletion protocols (13,14).
The aims of this study were firstly to determine
whether EVs present in FBS can influence cultured cells
phenotype such as the migration of an airway epithelial
cancer cells, and secondly to determine the efficiency
of elimination of EVs by different ultracentrifugation
protocols.
Material and methods
Cell cultures
The human lung epithelial cell line, A549 (ATCC), was
cultured in DMEM/F12 (1:1) medium (HyClone labora-
tories, Inc., Logan, UT), the human mast cell, HMC-1
(Dr. Joseph Butterfield, Mayo Clinic, Rochester, MN,
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Karolinska Institute, Stockholm, Sweden), was cultured
in IMDM (Sigma Aldrich, St. Louis, MO) and the mouse
fibroblast cell line, NIH3T3 (ATCC), was cultured in
DMEM (with Glutamine; HyClone laboratories, Inc.).
All media was supplemented with 10% FBS, 100 units/ml
penicillin and 100 mg/ml streptomycin (HyClone labora-
tories, Inc.). Additional, 2 mM L-glutamine (HyClone
laboratories, Inc.) and 1.2 mM alpha-thioglycerol (Sigma
Aldrich) were added to the HMC-1 cell media. All
supplement FBS was depleted of EVs by ultracentrifuga-
tion for 18 hours at 120,000g (Type 45 Ti rotor, 38, 800
rpm, k-factor 178.6, Beckman coulter, Brea, CA) unless
it is specifically mentioned as non-depleted. All cells were
cultured at 378C and 5% CO2.
Isolation of FBS-derived extracellular vesicles for
characterization
FBS was purchased from Sigma Aldrich and had been
filtered (0.1 mm) by the manufacturer prior to purchase.
The FBS was subjected to 18 hours (overnight) centri-
fugation at 120,000g (Type 45 Ti rotor, Beckman
Coulter). The pellet was washed by adding PBS, and
placing the sample under gentle agitation until the pellet
was dissolved, before filtering it (0.2 mm) and re-pelleting
itwithanultracentrifugationat120,000gfor70minutes.
Analysis of FBS vesicles depletion protocols
In order to test EVs depletion protocols, FBS was either
kept undiluted or were diluted with PBS in a ratio of
3:7 (FBS:PBS). These preparations were then subjected to
1.5 hours or 18 hours (overnight) centrifugation at
120,000g (Type 45 Ti rotor, Beckman Coulter). The su-
pernatantswerethenused to prepare 10% FBS-containing
mediumthatwasneverincontactwithcells.The10%FBS-
containing medium was later subjected to a standard
exosome isolation protocol using differential centrifuga-
tion previously described (14). Briefly the FBS-containing
medium was centrifuged sequentially at 300g (10
minutes) to remove debris and at 16,500g (20 minutes)
to remove large vesicles. Furthermore the supernatant was
filtered with 0.2 mm filter before the samples were
centrifuged at 120,000g (70 minutes) to pellet exosomes.
Reverse migration assay
To evaluate the migratory phenotype of lung epithelial
cells (A549), reverse migration assay was performedwith a
46-well Boyden chamber (Neuroprobe Inc., Gaithersburg,
MD) asreported (15). Briefly, 20,000 cells/wellwereadded
to the lower chamber and were allowed to adhere onto
the gelatin coated (0.1%) polycarbonate membrane by
inverting the chamber assembly upside down for 3 hours.
Later the chamber was placed in the correct orientation
and incubated for 12 hours with various FBS-EV dosages
in the upper chamber, which is the opposite side of the
membrane in relation to the cells. The membrane was
then carefully removed, and cells on the migrated side
were fixed in ethanol, and stained with Giemsa (Histolab,
Gothenburg, Sweden). Cells from the non-migrated side
were wiped out completely before acquiring images with a
light microscope (Zeiss Axioplan, Gottingen, Germany).
RNA isolation and detection
RNA was isolated from the different pellets described in
the ‘‘Isolation of FBS-derived extracellular vesicles for
characterization’’ and ‘‘Analysis of FBS vesicles depletion
protocols’’ sections, using miRCURY
TM RNA Isolation
Kit for Cell and Plant (Exiqon, Vedbaek, Denmark)
according to manufacturer’s protocol and as described
previously (16). One microliter of isolated RNA was
analyzed for its quality, yield and nucleotide length with
capillary electrophoresis using Agilent RNA 6000 Pico
chip on an Agilent 2100 Bioanalyzer† (Agilent Technol-
ogies, Santa Clara, CA).
Proteinase and RNase protection assay
For this assay, washed pellets obtained according to the
method section ‘‘Isolation of FBS-derived extracellular
vesicles for characterization’’ was used. Isolated vesicles
were incubated with proteinase K (0.05 mg/ml; Sigma
Aldrich) for 10 minutes at 378C, before 5 mM phenyl-
methylsulfonyl fluoride (PMSF; Sigma Aldrich) was
added for 10 minutes at room temperature to inhibit the
proteinase K activity. Proteinase K activity was further
inhibited by incubating the solution at 908C for 5 minutes.
After the inactivation of proteinase K, the samples were
incubated with RNase A (final concentration 0.5 mg/ml;
Thermo Fischer Scientific, Waltham, MA) for 20 minutes
at 378C to degrade unprotected RNA. Finally RNA was
extracted and profiled as described earlier. Control
samples were treated equally, but with PBS added instead
of proteinase K, PMSF and/or RNase A. Furthermore,
one control was kept at 48C.
Transmission electron microscopy
Transmission electron microscopy (TEM) was perfor-
med on the EV pellet isolated as described in section
‘‘Isolation of FBS-derived extracellular vesicles for char-
acterization’’ as well as on the EV pellet isolated from the
10% FBS media using the 18 hours depletion protocol
described in ‘‘Analysis of FBS vesicles depletion proto-
cols.’’ Fifteen microgram of sample was loaded onto
UV treated (5 minutes) formvar/carbon-coated nickel
grids (Ted Pella Inc., Redding, CA) and incubated for
10 minutes before adding 2% paraformaldehyde for
fixation. Later the samples were further fixed in 2.5%
glutaraldehyde and contrasted in 2% uranyl acetate.
Prepared samples were observed under a LEO 912AB
Omega electron microscope (Carl Zeiss NTS, Jena,
Germany).
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EV pellet obtained as described in the ‘‘Isolation of
FBS-derived extracellular vesicles for characterization’’
method section was labelled with PKH67 Green Fluor-
escent Cell Linker Kit (Sigma Aldrich) as per manufac-
turer’s protocol, with minor modifications in the washing
process as previously described (8). Briefly, vesicles in PBS
corresponding to 25 mg were added to 1 ml of diluent C.
As a control equivalent 1 ml of diluent C was mixed with
the same volume of PBS as was taken for the 25 mg
exosomes. To this 4 ml of PKH67 dye each was added.
After gentle mixing of samples for 4 minutes, 2 ml of 1%
BSA was added to reduce the unbound dye. Both the
samples were then transferred to 300 kDa Vivaspin filters
(Sartorius Stedim Biotech GmbH, Goettingen, Germany)
and centrifuged at 4,000g. Proper washing was per-
formed with 5 ml of PBS three times before PKH67-
labelled vesicles were incubated with the lung epithelial
cell line A549 ( 70,000 cells) for 6 or 20 hours. Cellswere
washed with PBS, before being fixed in 4% paraformalde-
hyde. Samples were imaged under a fluorescence light
microscope (Zeiss Axioplan, Germany).
Western Blot analysis
For immuno-blotting, the vesicle used was isolated as
described in ‘‘Isolation of FBS-derived extracellular
vesicles for characterization’’ method section. Further-
more, cell lysate and HMC-1 exosomes were used as
positive control. All sampleswere lysed in 1X RIPA buffer
(Cell Signaling Technology ST, Danvers, MA) with
15 minutes of sonication with intermittent vortex-mixing,
followed by centrifugation at 20,000g for 12 minutes
at 48C. Protein estimation was performedwith BCA assay
as per product manual (Pierce
TM BCA Protein Assay
Kit, Rockford, IL). One hundred micrograms of protein
lysate were subjected to SDS-PAGE and proteins were
transferred onto nitrocellulose membranes. Membranes
were blocked with 5% Blotting Grade Blocker Non-
Fat Dry Milk in TBS containing 0.05% Tween-20 and
probed with the following antibodies: CD63 (1:1,000;
clone H-193; Santa Cruz Biotechnology, Santa Cruz,
CA),TSG101 (1:1,000; clone 4A10; Abcam, Cambridge,
UK), and CD81 (1:800; clone H-121; Santa Cruz Bio-
technology). The membranes were then incubated
for one hour with the secondary antibodies diluted in
0.25% Blotting Grade Blocker Non-Fat Dry Milk in
TBST. The secondary antibodies used were; donkey
anti-rabbitIgGHRP-linkedF(ab’)2fragment(1:10,000)and
sheep anti-mouse IgG HRP-linked F(ab’)2 fragment
(1:2,000), both from GE Healthcare, Buckinghamshire,
UK. The probed proteins were detected with the ECL
Prime Western Detection (GE Healthcare, Amersham
Buckinghamshire, UK) and a VersaDoc 4000 MP
(Bio-Rad Laboratories) according to the manufacturer’s
protocol.
Statistical methods
Statistical analyses were performed using Student’s t-test
and Kruskal-Wallis test, and pB0.05 was considered
significant. All scores in dose response studies are Spear-
man Rank Correlations. All experiments were performed
on at least three different occasions.
Result
Effect of fetal bovine serum on epithelial cell
migration
FBS has previously been shown to induce cell migration
(17) and has been used as positive control in migration
assays (18). We hypothesized that EVs present in the FBS
could in whole or partially contribute to this phenotype
change in cells. The effect of FBS, depleted or non-
depleted of EVs, on reversed migration of the airway
epithelial cell line A549, is shown in Fig. 1. Medium
supplemented with FBS not depleted of EVs resulted
in the transmigration of  250 cells per field. Medium
supplemented with FBS depleted of EVs resulted in a
significantly reduced number of transmigrated cells, only
somewhat higher than medium alone.
Isolation and characterization of fetal bovine
serum-derived extracellular vesicles
We hypothesized that the migratory effects observed by
the FBS that had not been depleted of EVs indeed could
be explained by their EVs. Although the presence of
EVs in FBS has been known for over 40 years (19) and
has been discussed previously within the exosome field
(11,12), to our knowledge these vesicles has not been
characterized in depth previously. Therefore, we isolated
FBS-derived EVs and performed additional characteriza-
tion and functional experiments. The presenceof vesicular
structures was determined by TEM in the EV-enriched
pellet from FBS (Fig. 2a). The presence of the ‘‘exosome
markers’’ TSG101 using anti-human antibodies was
detected in cell lysates from both mouse NIH3T3 cells
and human HMC-1 cells, but also in the FBS EVs pellet
from two separate batches of FBS (Fig. 2b, uncropped
images of the Western blot membranes and background
are provided in Supplementary Figure 1). An anti-human
CD81 antibody signal was also detected in all FBS
EVs preparation but not in equivalent cellular protein
lysate showing the enrichment of CD81 in FBS-derived
EVs. Another ‘‘exosome marker’’ CD63 was also de-
tected in the FBS-derived EV pellet of one of the FBS
batches (Fig. 2b). The positive binding of anti-human
antibodies to mouse cell lysates and FBS-derived EVs
could most likely be explained by the very high homology
among species for the epitopes studied, which is up to
95% (CLUSTALW-multiple sequence alignment tool:
www.ebi.ac.uk).
Fetal bovine serum exosomes
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Fig. 1. Depletion of extracellular vesicles reduces FBS-induced cell migration. Medium was either supplemented with 10% FBS
(Medium, non-depleted FBS) or 10% FBS that had been centrifuged for 18 hours to eliminate extracellular vesicle (Medium,
EV-depleted FBS). As a control, FBS-free media was used (Plain medium). A549 cells were seeded on one side of a gelatin coated
membrane of a Boyden chamber to evaluate cellular transmigration towards the various stimuli on the other side of the membrane.
Student’s t-test was used to determine signiﬁcant differences, *pB0.05, ***pB0.001. n3.
Fig. 2. Characterization of FBS-derived extracellular vesicles. FBS-derived vesicles were collected at 120,000g for 18 hours, dissolved
in PBS and re-pelleted at 120,000g for 70 minutes. a) To visualize if FBS had vesicular structures present, TEM was performed on the
EV-enriched pellet. The scale bar represents 200 nm. b) Immuno-blotting for the exosome enriched proteins; TSG101, CD81, and
CD63. Pellet of EVs were obtained from different batch of FBS. Cell lysate from human mast cells (HMC-1) and mouse ﬁbroblast
(NIH-3T3), as well as HMC-1 derived exosomes were used as positive controls. One hundred microgram of protein was loaded per well
for all samples. c) RNA was isolated using the miRCURY total RNA isolation kit and quantiﬁed with a Bioanalyzer. d) The FBS-
derived EV-enriched pellet was incubatedwith RNase A (0.5 mg/ml) alone (i) or was incubatedwith proteinase K (0.05 mg/ml) prior to the
RNase treatment (ii) to study mode of RNA protection. Cellular RNA was used as control for the RNase activity (iii). Graphs are
representative of the RNA proﬁle obtained with a Bioanalyzer from two independent experiments. e) PKH67-labelled FBS-derived EVs
were incubated with 710
4cells (A549) for 6 or 20 hours and visualized with a ﬂuorescent microscope (40X). PBS was used as control
for determining the PKH67 background labelling.
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contains a typical exosomal RNA profile, as determined
by Bioanalyzer (Fig. 2c). Hence, the RNA profile shows
abundant RNAs of 60500 bases, with very small or
undetectable 18S and 28S ribosomal RNA peaks.
To determine whether the RNA obtained from the EV-
enriched FBS pellets is present in vesicles or in protein
RNA complexes, the samples were treated with RNase,
with or without pre-treatment with proteinase K. Protei-
nase K treatment of a cell lysate protein mixture (at
the same enzyme concentration as for vesicles) resulted
in total degradation of proteins, shown by an SDS gel
(Supplementary Figure 2; lane 3). The effect of proteinase
K was totally inhibited by the addition of a blocker
molecule (PMSF; Supplementary Figure 2; lane 2).
Figure 2d shows that the RNA profiles from the FBS
pellets were protected from RNase treatment, also after
combined proteinase K and RNase treatment (Fig. 2d i
and ii). RNase treatment of isolated cellular RNA
resulted in total elimination of the unprotected RNA,
showing that the RNase is active (Fig. 2d iii).
To determine whether EVs from FBS can be taken up
by A549 cells, the isolated FBS-derived EVs were labelled
using a lipid fluorescent dye (PKH67), andwereincubated
with the A549 cells for different periods of time. Fluor-
escent microscopy revealed the association offluorescence
lipid dye (PKH67) as punctate structures inside the cells.
Similar fluorescence patterns are observed at 6 and
20 hours after addition of the vesicles to the cells (Fig. 2e).
Induced migratory effect by FBS-derived EVs
In order to evaluate whether the depleted EVs from FBS
directly could induce a cell migratory phenotype, the
washed FBS-derived EVs alone were used as a chemoat-
tractant for A549 cells, and reversed transmigration was
evaluated. Briefly, the A549 cells were allowed to attach
to the membrane on the lower chamber side for 3 hours
before the EVs were added at different concentrations
to the upper chamber. After 12 hours the membrane was
then carefully detached, and cells on the lower chamber
side were removed before the cells on the upper chamber
side were fixed and stained. Images were acquired with
a light microscope (Supplementary Figure 3), and the
number of migrating cells was counted. The addition of
medium without FBS resulted in the transmigration
of  90 cells per field, whereas the addition of 0.03
100 mg/ml of FBS-derived EVs (protein weight) resulted
in the transmigration of 138234 cells per field, in a
statistically significant (Kruskal-Wallis test: pB0.001)
dose-dependent manner (Fig. 3).
Efficiency of centrifugation-based depletion protocol
for the removal of FBS EVs containing RNA
The recommended protocol for eliminating FBS EVs is
to centrifuge the FBS for 18 hours at 100,000g (13).
However, a protocol using a 1.5-hour centrifugation only
is also used by some investigators. To our knowledge the
efficiency of these established FBS-EV depletion proto-
cols to reduce EVs has not been evaluated. We therefore
centrifuged the FBS at 120,000g for a long (18 hours)
and short (1.5 hours) period, and obtained superna-
tant was used to supplement media at 10%. An exosome
isolation protocol was then applied on this medium
that had never been in contact with cultured cells, and
EV RNA was quantified (Fig. 4a and b). The longer
centrifugation period reduced the RNA by  95%,
whereas the short centrifugation only did so by approxi-
mately  50%. We also continued to verify the efficiency
of RNA depletion after reducing the viscosity of the FBS.
To do this, we diluted the FBS in PBS at a 3:7 ratio,
before the 1.5 and 18 hours depletion ultracentrifugation
protocol was applied. EV RNA was evaluated similarly
as mentioned above (Supplementary Figure 3) and im-
portantly, there was no significant difference between
the depletion protocols using diluted and undiluted FBS
(142937 ng/ml after 1.5 hours centrifugation of diluted
FBS compared to 138920 ng/ml after 1.5 hours of
undiluted FBS, and 2999 ng/ml after 18 hours centrifu-
gation of diluted FBS compared to 1798 ng/ml after
18 hours of undiluted FBS).
Despite reducing the EV-associated RNA with over
95% EVs could still be detected with electron microscopy
in medium supplemented with FBS centrifuged for
18 hours prior to use in medium (Fig. 4c).
Fig. 3. FBS-derived extracellular vesicles induce migratory
phenotype in an epithelial cell line. FBS-derived EVs were
collected at 120,000g for 18 hours, washed in PBS and re-
pelleted for 70 minutes at 120,000g. Isolated vesicles were
incubated with A549 cells, but were separated by a gelatin coated
membrane in a Boyden chamber to evaluate cellular transmigra-
tion towards variable EVs concentrations. FBS-derived EVs
showed a dose-dependent response in inducing migration in
A549 cells. Kruskal-Wallis test was used to determine signiﬁcant
differences. Comparisons were only made against the control.
*pB0.05, **pB0.01, ***pB0.001. n3. Spearman Rank gave a
signiﬁcant correlation of Rs0.82.
Fetal bovine serum exosomes
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FBS is often used to supplement culture medium in
cell biology experiments, argued to provide ‘‘nutrients
and growth factors.’’ Importantly, commercially available
FBS contains many EVs, including exosomes, despite
having been filtered. We here show that FBS-induced
migration of an airway epithelial cancer cell line (A549)
is reduced when the FBS EVs are removed, and that FBS
EVs have a direct migratory effects on the same cells.
We have characterized the FBS-derived EVs, showing the
presence of exosome-like vesicles by electron microscopy,
and a positive signal in Western blot using anti-human
TSG101, CD81 and CD63, despite the vesicles originat-
ing from bovine blood. Further, typical exosome-like
RNA profiles with primarily short RNA is observed in
the FBS-derived EVs. The EVs from FBS are taken up
by epithelial cells, in a similar way to CD34
 cells taking
up mast cellderived EVs (20). A long centrifugation
period (18 hours) is required to remove the majority of
RNA-containing FBS EVs, while a 1.5-hour protocol is
insufficient.
Here, we show that FBS induces a migratory effect
in recipient A549 cells, and this effect is significantly
reduced by extended centrifugation, which is commonly
utilized to remove FBS EVs. Supplementing FBS in cell
cultures is commonly used to promote proliferation of
the cells studied, and to provide factors that improve
viability, such as nutrients and growth factors. However,
little is known about the role of the exosomes that are
present in FBS, although one earlier study argues that
they can promote proliferation of a breast cancer cell
line (10).
We therefore pursued with experiments to carefully
characterize FBS-derived EVs, using multiple methodol-
ogies. Firstly, the EVs derived directly from FBS have
a circular morphology, similar to exosomes as shown
previously by electron microscopy (1,5). Importantly,
there is no suggestion that FBS-derived EVs and EVs
derived from cell culture experiments or human body
fluids are different in morphology (5,8). Further, we
tested whether the FBS EVs would express markers
similar to human EVs, and Western blot showed the
presence of multiple ‘‘exosome markers,’’ including
TSG101, CD81 and CD63, using different antibodies.
Importantly, all the antibodies used in the present study
are considered to be directed towards multiple species,
and therefore the observed positivity in the FBS-derived
EVs is not surprising. Actually, the epitopes of the
antibodies used here for TSG101, CD81 and CD63 share
very high sequence similarity between bovine and human,
reaching approximately 99, 95 and 89%, respectively.
Importantly, the intention of this study was not to
determine the bovine binding of the ‘‘anti-human’’
antibodies, but to emphasize that EVs in FBS can be
positive for proteins that may be considered to be the
human proteins and have functional significance. Nota-
bly, the RNA profiles of FBS-derived EVs are very
similar to the RNA profiles seen in EVs isolated from
different human cell lines and body fluids (8,14). These
results obviously open the possibility that FBS EVs
c a nb em i s t a k e na sc e l l - d e r i v e dE V s .T h e r e f o r e ,i ti s
absolutely crucial to consider any contamination of FBS-
derived EVs in any studies of EVs produced in vitro in
the presence of FBS.
The RNA in FBS-derived EVs is resistant to direct
RNase A treatment, which shows that the RNA profiles
observed are not representing free RNA molecules.
In some experiments, however, the very small rRNA
peaks observed in the FBS-derived EVs disappeared
by RNase A treatment only, which could imply that the
ribosomal RNA may be present on the outside of the
lipid bilayer of FBS-derived EVs. When the FBS-derived
Fig. 4. Analysis of FBS vesicles depletion protocols. EV-depleted FBS was obtained from 1.5 and 18 hours of ultracentrifugation and
was used to prepare complete media (10% FBS). The media was never in contact with cells, but used to isolate exosomes from. The
RNAwas extracted from the 120,000g pellet and the concentration and nucleotide size was determined by a Bioanalyzer and the Pico
chip. a) Data represent the overlay of RNA proﬁle concentration of bovine RNA retained in complete media supernatant and pelleted
during exosome isolation. b) Efﬁciency of exosome depletion with different centrifugation period is compared based on total RNA
content in their exosome preparation in complete media. Results represent mean9SEM of sample obtained from 36 independent
experiments. c) Presence of vesicular structures was determined by transmission electron microscopy. Vesicles are from the pellet
preparation from EV-depleted FBS after 18 hours of ultracentrifugation (Bar represents 200 nm).
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all proteins but will not penetrate the lipid bilayer,
followed by RNase A treatment (Fig. 2d ii), the small RNA
profiles were largely preserved. This argues that the RNA
captured in the FBS-EV pellet is not harboured inside
protein structures, but rather protected by a lipid bilayer
resistant to proteinase K. This is important, as it has
been shown that several extracellular proteins, includ-
ing AGO-2 and HDL, can protect RNA molecules from
RNase degradation (21,22). Therefore, our data collec-
tively argue that most of the RNA in FBS is present
inside EVs, and is thus protected from the RNase-rich
extracellular environment.
It is well known that EVs can be taken up by cells,
and can deliver their cargo to recipient cells by unknown
intracellular molecular pathways. In a separate experi-
ment, we showed that FBS-derived EVs, stained with
a lipid dye, are rapidly taken up by the recipient A549
cells. This shows a similar time line as the uptake of mast
cellderived EVs in human CD34
 cells (20), and sug-
gests that interspecies uptake of EVs can occur, support-
ing earlier reports (23). Indeed, our original study of
‘‘exosomes’’ from a mouse mast cell line (MC/9) showed
that these vesicles could be taken up by human mast cells
(HMC-1) (23). These data again argue that any research
group pursuing experiments studying uptake of EVs in
recipient cells needs to harvest those EVs from cells that
are cultured without the presence of FBS EVs. However,
the data also support the concept that EVs can transfer
materials across species.
We could also show that the isolated FBS-derived
EVs have a direct migratory dose-dependent effect on the
airway epithelial cancer cell line (A549 cells), which again
clarifies the importance to consider the role of FBS EVs
on cell phenotype and behaviour. Some studies have
suggested that there is large alteration in gene expression
in cells when cultured in FBS compared to know growth
factors supplements (24). However, very few studies have
looked at the direct effect of FBS-derived EVs on cell
physiology. Nevertheless, in 2009, Ochieng et al. showed
that anchorage-independent breast cancer growth was
promoted by FBS vesicles (10). The previous study and
our current study thus show that it is crucial to consider
the overall involvement and importance of FBS EVs
in any cell culture studies, but it is possible that FBS EVs
influence also other cellular processes in vitro.
The effect of FBS that has not undergone an ‘‘exosome
depletion protocol’’ on cell behaviour in vitro has im-
portant implications for anyone performing cell cultures
in the presence of FBS. Thus, we here show that over-
night centrifugation removes most of the FBS-mediated
effect on cell migration, and also removes most of the
EV RNA (Fig. 4). Often, shorter protocols to remove
FBS EVs are utilized, but clearly they are not sufficient
to get virtually ‘‘EV-RNA free FBS.’’ With an 18-hour
centrifugation, we remove more than 95% of EV RNA,
but still some EVs can be visualized by electron micro-
scopy. Therefore, it is clear that no ‘‘depletion protocol’’
leads to total FBS-EV elimination, even though most of
them are eliminated. Importantly, also, any RNA analysis
of primary or cell line cultures that include high concen-
trations of FBS, must consider the possible influence of
the RNA added by the EVs from FBS. FBS EVs and their
associated cargo, additional to growth factors and other
small soluble molecules, are important for the influence of
FBSoncellmigration,andshouldbeconsidertoinfluence
also other cellular functions.
Overall, this study shows that RNA-containing EVs
in FBS can be removed to almost 95% with an 18 hours
centrifugation protocol, and this approach strongly
reduce the functionality of FBS vesicles on epithelial
cell migration. Shorter protocols only reduce the pres-
ence of FBS EVs in the cell culture medium to a smaller
extent, which still can have significant effects of cell
physiology and phenotype.
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